Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosis

IF 2.2 4区 医学 Q3 RESPIRATORY SYSTEM Respiratory Medicine and Research Pub Date : 2023-11-30 DOI:10.1016/j.resmer.2023.101073
Arshan Dehbozorgi , Badr Jandali , Robert Turner , Aaron Rohr , Brandon Custer , Kate Young , Carissa Walter , Lauren Clark , Yanming Li , Deepika Polineni , Joel Mermis
{"title":"Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosis","authors":"Arshan Dehbozorgi ,&nbsp;Badr Jandali ,&nbsp;Robert Turner ,&nbsp;Aaron Rohr ,&nbsp;Brandon Custer ,&nbsp;Kate Young ,&nbsp;Carissa Walter ,&nbsp;Lauren Clark ,&nbsp;Yanming Li ,&nbsp;Deepika Polineni ,&nbsp;Joel Mermis","doi":"10.1016/j.resmer.2023.101073","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Peripherally inserted central catheters (PICCs) are the most common route of intravenous (I.V.) access for treatment of cystic fibrosis (CF) pulmonary exacerbations, but repeated PICC placement can result in upper extremity peripheral venous stenosis. Once peripheral stenosis develops, a non-cuffed tunneled central venous catheter (NcTCVC) is an alternative route for IV access. While these are regularly used at some CF centers, the safety and complication rate compared to PICCs in adults with CF has not been reported. This study aims to describe the safety of NcTCVCs in adults with CF.</p></div><div><h3>Methods</h3><p>A retrospective cohort study was performed at a CF Foundation accredited institution including adults with CF who received NcTCVCs in interventional radiology from 7/19/2007 to 3/09/2020. Complications analyzed included catheter related deep venous thrombosis (DVT), central line associated blood stream infection (CLABSI), and catheter related central venous stenosis. Complications were considered attributable if they occurred while the catheter was in place or within 30 days of catheter removal.</p></div><div><h3>Results</h3><p>During the study duration, 386 NcTCVCs were placed in 60 unique patients (55 % female) with a mean of 6.4 catheters per patient. Majority of NcTCVCs placed were 4 French (61.4 %). Average duration of indwelling NcTCVC was 16.2 days. No patients demonstrated catheter attributable symptomatic DVT. The incidence of DVT, CLABSI, and central venous stenosis was 0 (0 %), 4 (1 %), and 1 (0.3 %), respectively.</p></div><div><h3>Conclusions</h3><p>Many adults with CF have required insertion of numerous PICCs for the treatment of recurrent pulmonary exacerbations. In those adults that develop PICC-associated peripheral vein stenosis precluding PICC placement, these results indicate NcTCVCs are a safe alternative.</p></div>","PeriodicalId":48479,"journal":{"name":"Respiratory Medicine and Research","volume":"85 ","pages":"Article 101073"},"PeriodicalIF":2.2000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590041223000855/pdfft?md5=4ca6b4ec9bb6e7de247329c33407007a&pid=1-s2.0-S2590041223000855-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine and Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590041223000855","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Peripherally inserted central catheters (PICCs) are the most common route of intravenous (I.V.) access for treatment of cystic fibrosis (CF) pulmonary exacerbations, but repeated PICC placement can result in upper extremity peripheral venous stenosis. Once peripheral stenosis develops, a non-cuffed tunneled central venous catheter (NcTCVC) is an alternative route for IV access. While these are regularly used at some CF centers, the safety and complication rate compared to PICCs in adults with CF has not been reported. This study aims to describe the safety of NcTCVCs in adults with CF.

Methods

A retrospective cohort study was performed at a CF Foundation accredited institution including adults with CF who received NcTCVCs in interventional radiology from 7/19/2007 to 3/09/2020. Complications analyzed included catheter related deep venous thrombosis (DVT), central line associated blood stream infection (CLABSI), and catheter related central venous stenosis. Complications were considered attributable if they occurred while the catheter was in place or within 30 days of catheter removal.

Results

During the study duration, 386 NcTCVCs were placed in 60 unique patients (55 % female) with a mean of 6.4 catheters per patient. Majority of NcTCVCs placed were 4 French (61.4 %). Average duration of indwelling NcTCVC was 16.2 days. No patients demonstrated catheter attributable symptomatic DVT. The incidence of DVT, CLABSI, and central venous stenosis was 0 (0 %), 4 (1 %), and 1 (0.3 %), respectively.

Conclusions

Many adults with CF have required insertion of numerous PICCs for the treatment of recurrent pulmonary exacerbations. In those adults that develop PICC-associated peripheral vein stenosis precluding PICC placement, these results indicate NcTCVCs are a safe alternative.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
成人囊性纤维化患者使用无袖带隧道式中心静脉导管的安全性。
背景:外周置入中心静脉导管(PICC)是治疗囊性纤维化(CF)肺部恶化最常见的静脉(I.V.)通路,但反复置入 PICC 会导致上肢外周静脉狭窄。一旦出现外周静脉狭窄,无袖带隧道中心静脉导管(NcTCVC)是静脉通路的替代途径。虽然一些 CF 中心经常使用这种导管,但与 PICC 相比,NcTCVC 在 CF 成人患者中的安全性和并发症发生率尚未见报道。本研究旨在描述 NcTCVC 在成人 CF 患者中的安全性:一项回顾性队列研究在一家获得 CF 基金会认证的机构进行,研究对象包括 2007 年 7 月 19 日至 2020 年 9 月 3 日期间在介入放射科接受 NcTCVC 的 CF 成人患者。分析的并发症包括导管相关深静脉血栓(DVT)、中心静脉相关血流感染(CLABSI)和导管相关中心静脉狭窄。如果并发症发生在导管放置期间或导管拔出后 30 天内,则视为可归因于导管:在研究期间,共为 60 名患者(55% 为女性)置入了 386 根 NcTCVC,平均每名患者置入 6.4 根导管。大多数 NcTCVC 导管为 4 French 导管(61.4%)。留置 NcTCVC 的平均时间为 16.2 天。没有患者出现因导管引起的无症状深静脉血栓。深静脉血栓、CLABSI和中心静脉狭窄的发生率分别为0(0%)、4(1%)和1(0.3%):许多成年 CF 患者需要插入大量 PICC 来治疗反复发作的肺部恶化。对于那些因 PICC 相关外周静脉狭窄而无法置入 PICC 的成人,这些结果表明 NcTCVC 是一种安全的替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Medicine and Research
Respiratory Medicine and Research RESPIRATORY SYSTEM-
CiteScore
2.70
自引率
0.00%
发文量
82
审稿时长
50 days
期刊最新文献
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study. Prognosis of incidental lung cancer in lung transplant candidates. Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial. Pleural ultrasound for pneumothorax diagnosis after computerised tomography-guided biopsy Physical activity and idiopathic pulmonary fibrosis: A prospective cohort study in UK Biobank and Mendelian randomization analyses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1